Κυκλοφωσφαμίδη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Κυκλοφωσφαμίδη" in Greek language version.

refsWebsite

Global rank Greek rank

45nih.gov

4^th place

34doi.org

2^nd place

3^rd place

6archive.org

6^th place

5^th place

3web.archive.org

1^st place

2worldcat.org

5^th place

8^th place

1cancer.gov

1,684^th place

784^th place

1drugs.com

399^th place

130^th place

1medicinescomplete.com

low place

5,144^th place

1biomedcentral.com

2,747^th place

4,853^rd place

1zenodo.org

621^st place

1,469^th place

1aspetjournals.org

6,663^rd place

9,745^th place

archive.org

«Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis». The Journal of Rheumatology 18 (2): 188–94. February 1991. PMID 1673721. https://archive.org/details/sim_journal-of-rheumatology_1991-02_18_2/page/188.
«Pulmonary effects of cytotoxic agents other than bleomycin». Clinics in Chest Medicine 11 (1): 31–54. March 1990. PMID 1691069. https://archive.org/details/sim_clinics-in-chest-medicine_1990-03_11_1/page/31.
«NIH conference. Lupus nephritis». Annals of Internal Medicine 106 (1): 79–94. January 1987. doi:10.7326/0003-4819-106-1-79. PMID 3789582. https://archive.org/details/sim_annals-of-internal-medicine_1987-01_106_1/page/79.
«Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency». Kidney International 61 (4): 1495–501. April 2002. doi:10.1046/j.1523-1755.2002.00279.x. PMID 11918757. https://archive.org/details/sim_kidney-international_2002-04_61_4/page/1495.
«Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect». Cancer Treatment Reports 60 (4): 395–401. April 1976. PMID 1277213. https://archive.org/details/sim_cancer-treatment-reports_1976-04_60_4/page/395.
«Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective». Cancer Treatment Reports 60 (4): 337–46. April 1976. PMID 1277209. https://archive.org/details/sim_cancer-treatment-reports_1976-04_60_4/page/337.

aspetjournals.org

jpet.aspetjournals.org

«Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat». The Journal of Pharmacology and Experimental Therapeutics 174 (2): 206–10. August 1970. PMID 4393764. Αρχειοθετήθηκε από το πρωτότυπο στις 2021-08-28. https://web.archive.org/web/20210828052431/https://jpet.aspetjournals.org/content/174/2/206.long. Ανακτήθηκε στις 2020-11-02.

biomedcentral.com

systematicreviewsjournal.biomedcentral.com

Singh, Jasvinder A.; Hossain, Alomgir; Kotb, Ahmed; Wells, George A. (2016). «Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis» (στα αγγλικά). Systematic Reviews 5 (1): 155. doi:10.1186/s13643-016-0328-z. ISSN 2046-4053. PMID 27619512. PMC 5020478. http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0328-z.

cancer.gov

«NCI Drug Dictionary». National Cancer Institute. 2 Φεβρουαρίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Απριλίου 2015. Ανακτήθηκε στις 20 Δεκεμβρίου 2016.

doi.org

dx.doi.org

«Updates in ANCA-associated vasculitis». European Journal of Rheumatology 3 (3): 122–133. September 2016. doi:10.5152/eurjrheum.2015.0043. PMID 27733943.
La Mantia, L.; Milanese, C.; Mascoli, N.; D'Amico, R.; Weinstock-Guttman, B. (2007-01-24). «Cyclophosphamide for multiple sclerosis». Cochrane Database of Systematic Reviews (1): CD002819. doi:10.1002/14651858.CD002819.pub2. ISSN 1469-493X. PMID 17253481.
«Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus». Rheumatology 56 (suppl_1): i100–i113. April 2017. doi:10.1093/rheumatology/kew417. PMID 28375452.
Singh, Jasvinder A.; Hossain, Alomgir; Kotb, Ahmed; Wells, George A. (2016). «Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis» (στα αγγλικά). Systematic Reviews 5 (1): 155. doi:10.1186/s13643-016-0328-z. ISSN 2046-4053. PMID 27619512. PMC 5020478. http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0328-z.
«Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment». American Journal of Hematology 89 (12): 1132–40. December 2014. doi:10.1002/ajh.23828. PMID 25407896.
«The evolution of T-cell depletion in haploidentical stem-cell transplantation». British Journal of Haematology 172 (5): 667–84. March 2016. doi:10.1111/bjh.13868. PMID 26684279.
«HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide». Bone Marrow Transplantation 50 Suppl 2: S31–6. June 2015. doi:10.1038/bmt.2015.92. PMID 26039204.
«Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide». Seminars in Hematology 53 (2): 90–7. April 2016. doi:10.1053/j.seminhematol.2016.01.005. PMID 27000732.
«Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?». American Journal of Medical Genetics 86 (3): 237–41. September 1999. doi:10.1002/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.0.CO;2-V. PMID 10482872.
«The problem of permanent bone marrow damage after cytotoxic drug treatment». Oncology 41 (3): 180–4. 1984. doi:10.1159/000225819. PMID 6374556.
«Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis». BMC Medicine 14 (1): 137. September 2016. doi:10.1186/s12916-016-0673-8. PMID 27623861.
«Lung toxicity associated with cyclophosphamide use. Two distinct patterns». American Journal of Respiratory and Critical Care Medicine 154 (6 Pt 1): 1851–6. December 1996. doi:10.1164/ajrccm.154.6.8970380. PMID 8970380.
«Cardiotoxicity of cancer therapy». Journal of Clinical Oncology 23 (30): 7685–96. October 2005. doi:10.1200/JCO.2005.08.789. PMID 16234530.
«Water intoxication following moderate-dose intravenous cyclophosphamide». Archives of Internal Medicine 145 (3): 548–9. March 1985. doi:10.1001/archinte.145.3.548. PMID 3977522.
«Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus». Lupus 12 (8): 636–9. 2003. doi:10.1191/0961203303lu421cr. PMID 12945725.
«Cyclophosphamide and cancer: golden anniversary». Nature Reviews. Clinical Oncology 6 (11): 638–47. November 2009. doi:10.1038/nrclinonc.2009.146. PMID 19786984.
«Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review». Arthritis and Rheumatism 62 (1): 9–21. January 2010. doi:10.1002/art.25061. PMID 20039416.
«Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis». Lancet 340 (8822): 741–5. September 1992. doi:10.1016/0140-6736(92)92292-n. PMID 1356175. https://zenodo.org/record/1258313.
«Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus». Arthritis and Rheumatism 39 (9): 1475–82. September 1996. doi:10.1002/art.1780390906. PMID 8814058.
«When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases». Arthritis and Rheumatism 59 (7): 1034–9. July 2008. doi:10.1002/art.23822. PMID 18576286.
«Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis». European Journal of Clinical Investigation 45 (3): 346–68. March 2015. doi:10.1111/eci.12410. PMID 25627555.
«NIH conference. Lupus nephritis». Annals of Internal Medicine 106 (1): 79–94. January 1987. doi:10.7326/0003-4819-106-1-79. PMID 3789582. https://archive.org/details/sim_annals-of-internal-medicine_1987-01_106_1/page/79.
«Clinical pharmacokinetics of depot leuprorelin». Clinical Pharmacokinetics 41 (7): 485–504. 2002. doi:10.2165/00003088-200241070-00003. PMID 12083977.
«Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis». Archives of Internal Medicine 168 (4): 378–81. February 2008. doi:10.1001/archinternmed.2007.107. PMID 18299492.
«Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study». Arthritis and Rheumatism 38 (8): 1120–7. August 1995. doi:10.1002/art.1780380815. PMID 7639809.
«Etiology and management of therapy-related myeloid leukemia». Hematology. American Society of Hematology. Education Program 2007: 453–9. 2007. doi:10.1182/asheducation-2007.1.453. PMID 18024664.
«Prodrugs--from serendipity to rational design». Pharmacological Reviews 63 (3): 750–71. September 2011. doi:10.1124/pr.110.003459. PMID 21737530.
«Metabolism and pharmacokinetics of oxazaphosphorines». Clinical Pharmacokinetics 38 (4): 291–304. April 2000. doi:10.2165/00003088-200038040-00001. PMID 10803453.
«Cyclophosphamide in human milk». Lancet 1 (7705): 912. May 1971. doi:10.1016/s0140-6736(71)92474-3. PMID 4102054.
Giraud, B (2010), «Oxazaphosphorines: new therapeutic strategies for an old class of drugs», Expert Opin Drug Metab Toxicol 6 (8): 919–938, doi:10.1517/17425255.2010.487861, PMID 20446865
«Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency». Kidney International 61 (4): 1495–501. April 2002. doi:10.1046/j.1523-1755.2002.00279.x. PMID 11918757. https://archive.org/details/sim_kidney-international_2002-04_61_4/page/1495.
«Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies». Blood Reviews 6 (3): 163–73. September 1992. doi:10.1016/0268-960X(92)90028-O. PMID 1422285.
«Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines». Biochemical Pharmacology 34 (19): 3465–71. October 1985. doi:10.1016/0006-2952(85)90719-1. PMID 2996550.
«Immunomodulatory effects of cyclophosphamide and implementations for vaccine design». Seminars in Immunopathology 33 (4): 369–83. July 2011. doi:10.1007/s00281-011-0245-0. PMID 21611872.

drugs.com

«Cyclophosphamide». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 2 Ιανουαρίου 2017. Ανακτήθηκε στις 8 Δεκεμβρίου 2016.

medicinescomplete.com

Brayfield, A, επιμ. (9 Ιανουαρίου 2017). «Cyclophosphamide: Martindale: The Complete Drug Reference». MedicinesComplete. London, UK: Pharmaceutical Press. Ανακτήθηκε στις 12 Αυγούστου 2017.

nih.gov

ncbi.nlm.nih.gov

«Updates in ANCA-associated vasculitis». European Journal of Rheumatology 3 (3): 122–133. September 2016. doi:10.5152/eurjrheum.2015.0043. PMID 27733943.
La Mantia, L.; Milanese, C.; Mascoli, N.; D'Amico, R.; Weinstock-Guttman, B. (2007-01-24). «Cyclophosphamide for multiple sclerosis». Cochrane Database of Systematic Reviews (1): CD002819. doi:10.1002/14651858.CD002819.pub2. ISSN 1469-493X. PMID 17253481.
«Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus». Rheumatology 56 (suppl_1): i100–i113. April 2017. doi:10.1093/rheumatology/kew417. PMID 28375452.
Singh, Jasvinder A.; Hossain, Alomgir; Kotb, Ahmed; Wells, George A. (2016). «Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis» (στα αγγλικά). Systematic Reviews 5 (1): 155. doi:10.1186/s13643-016-0328-z. ISSN 2046-4053. PMID 27619512. PMC 5020478. http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0328-z.
«Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment». American Journal of Hematology 89 (12): 1132–40. December 2014. doi:10.1002/ajh.23828. PMID 25407896.
«The evolution of T-cell depletion in haploidentical stem-cell transplantation». British Journal of Haematology 172 (5): 667–84. March 2016. doi:10.1111/bjh.13868. PMID 26684279.
«HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide». Bone Marrow Transplantation 50 Suppl 2: S31–6. June 2015. doi:10.1038/bmt.2015.92. PMID 26039204.
«Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide». Seminars in Hematology 53 (2): 90–7. April 2016. doi:10.1053/j.seminhematol.2016.01.005. PMID 27000732.
«Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?». American Journal of Medical Genetics 86 (3): 237–41. September 1999. doi:10.1002/(SICI)1096-8628(19990917)86:3<237::AID-AJMG8>3.0.CO;2-V. PMID 10482872.
«Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis». The Journal of Rheumatology 18 (2): 188–94. February 1991. PMID 1673721. https://archive.org/details/sim_journal-of-rheumatology_1991-02_18_2/page/188.
«The problem of permanent bone marrow damage after cytotoxic drug treatment». Oncology 41 (3): 180–4. 1984. doi:10.1159/000225819. PMID 6374556.
«Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis». BMC Medicine 14 (1): 137. September 2016. doi:10.1186/s12916-016-0673-8. PMID 27623861.
«Pulmonary effects of cytotoxic agents other than bleomycin». Clinics in Chest Medicine 11 (1): 31–54. March 1990. PMID 1691069. https://archive.org/details/sim_clinics-in-chest-medicine_1990-03_11_1/page/31.
«Lung toxicity associated with cyclophosphamide use. Two distinct patterns». American Journal of Respiratory and Critical Care Medicine 154 (6 Pt 1): 1851–6. December 1996. doi:10.1164/ajrccm.154.6.8970380. PMID 8970380.
«Cardiotoxicity of cancer therapy». Journal of Clinical Oncology 23 (30): 7685–96. October 2005. doi:10.1200/JCO.2005.08.789. PMID 16234530.
«Water intoxication following moderate-dose intravenous cyclophosphamide». Archives of Internal Medicine 145 (3): 548–9. March 1985. doi:10.1001/archinte.145.3.548. PMID 3977522.
«Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus». Lupus 12 (8): 636–9. 2003. doi:10.1191/0961203303lu421cr. PMID 12945725.
«Cyclophosphamide and cancer: golden anniversary». Nature Reviews. Clinical Oncology 6 (11): 638–47. November 2009. doi:10.1038/nrclinonc.2009.146. PMID 19786984.
«Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review». Arthritis and Rheumatism 62 (1): 9–21. January 2010. doi:10.1002/art.25061. PMID 20039416.
«Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis». Lancet 340 (8822): 741–5. September 1992. doi:10.1016/0140-6736(92)92292-n. PMID 1356175. https://zenodo.org/record/1258313.
«Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus». Arthritis and Rheumatism 39 (9): 1475–82. September 1996. doi:10.1002/art.1780390906. PMID 8814058.
«When is it safe to stop Pneumocystis jiroveci pneumonia prophylaxis? Insights from three cases complicating autoimmune diseases». Arthritis and Rheumatism 59 (7): 1034–9. July 2008. doi:10.1002/art.23822. PMID 18576286.
«Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis». European Journal of Clinical Investigation 45 (3): 346–68. March 2015. doi:10.1111/eci.12410. PMID 25627555.
«NIH conference. Lupus nephritis». Annals of Internal Medicine 106 (1): 79–94. January 1987. doi:10.7326/0003-4819-106-1-79. PMID 3789582. https://archive.org/details/sim_annals-of-internal-medicine_1987-01_106_1/page/79.
«Clinical pharmacokinetics of depot leuprorelin». Clinical Pharmacokinetics 41 (7): 485–504. 2002. doi:10.2165/00003088-200241070-00003. PMID 12083977.
«Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis». Archives of Internal Medicine 168 (4): 378–81. February 2008. doi:10.1001/archinternmed.2007.107. PMID 18299492.
«Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study». Arthritis and Rheumatism 38 (8): 1120–7. August 1995. doi:10.1002/art.1780380815. PMID 7639809.
«Etiology and management of therapy-related myeloid leukemia». Hematology. American Society of Hematology. Education Program 2007: 453–9. 2007. doi:10.1182/asheducation-2007.1.453. PMID 18024664.
«Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat». The Journal of Pharmacology and Experimental Therapeutics 174 (2): 206–10. August 1970. PMID 4393764. Αρχειοθετήθηκε από το πρωτότυπο στις 2021-08-28. https://web.archive.org/web/20210828052431/https://jpet.aspetjournals.org/content/174/2/206.long. Ανακτήθηκε στις 2020-11-02.
«Prodrugs--from serendipity to rational design». Pharmacological Reviews 63 (3): 750–71. September 2011. doi:10.1124/pr.110.003459. PMID 21737530.
«Metabolism and pharmacokinetics of oxazaphosphorines». Clinical Pharmacokinetics 38 (4): 291–304. April 2000. doi:10.2165/00003088-200038040-00001. PMID 10803453.
«Cyclophosphamide in human milk». Lancet 1 (7705): 912. May 1971. doi:10.1016/s0140-6736(71)92474-3. PMID 4102054.
Giraud, B (2010), «Oxazaphosphorines: new therapeutic strategies for an old class of drugs», Expert Opin Drug Metab Toxicol 6 (8): 919–938, doi:10.1517/17425255.2010.487861, PMID 20446865
«Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency». Kidney International 61 (4): 1495–501. April 2002. doi:10.1046/j.1523-1755.2002.00279.x. PMID 11918757. https://archive.org/details/sim_kidney-international_2002-04_61_4/page/1495.
«Importance of pharmacokinetic studies on cyclophosphamide (NSC-26271) in understanding its cytotoxic effect». Cancer Treatment Reports 60 (4): 395–401. April 1976. PMID 1277213. https://archive.org/details/sim_cancer-treatment-reports_1976-04_60_4/page/395.
«Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies». Blood Reviews 6 (3): 163–73. September 1992. doi:10.1016/0268-960X(92)90028-O. PMID 1422285.
«Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines». Biochemical Pharmacology 34 (19): 3465–71. October 1985. doi:10.1016/0006-2952(85)90719-1. PMID 2996550.
«Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective». Cancer Treatment Reports 60 (4): 337–46. April 1976. PMID 1277209. https://archive.org/details/sim_cancer-treatment-reports_1976-04_60_4/page/337.
«Immunomodulatory effects of cyclophosphamide and implementations for vaccine design». Seminars in Immunopathology 33 (4): 369–83. July 2011. doi:10.1007/s00281-011-0245-0. PMID 21611872.

pubmedcentral.nih.gov

«Updates in ANCA-associated vasculitis». European Journal of Rheumatology 3 (3): 122–133. September 2016. doi:10.5152/eurjrheum.2015.0043. PMID 27733943.
«Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus». Rheumatology 56 (suppl_1): i100–i113. April 2017. doi:10.1093/rheumatology/kew417. PMID 28375452.
Singh, Jasvinder A.; Hossain, Alomgir; Kotb, Ahmed; Wells, George A. (2016). «Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis» (στα αγγλικά). Systematic Reviews 5 (1): 155. doi:10.1186/s13643-016-0328-z. ISSN 2046-4053. PMID 27619512. PMC 5020478. http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0328-z.
«HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide». Bone Marrow Transplantation 50 Suppl 2: S31–6. June 2015. doi:10.1038/bmt.2015.92. PMID 26039204.
«Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide». Seminars in Hematology 53 (2): 90–7. April 2016. doi:10.1053/j.seminhematol.2016.01.005. PMID 27000732.
«Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis». BMC Medicine 14 (1): 137. September 2016. doi:10.1186/s12916-016-0673-8. PMID 27623861.

web.archive.org

«NCI Drug Dictionary». National Cancer Institute. 2 Φεβρουαρίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Απριλίου 2015. Ανακτήθηκε στις 20 Δεκεμβρίου 2016.
«Cyclophosphamide». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 2 Ιανουαρίου 2017. Ανακτήθηκε στις 8 Δεκεμβρίου 2016.
«Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat». The Journal of Pharmacology and Experimental Therapeutics 174 (2): 206–10. August 1970. PMID 4393764. Αρχειοθετήθηκε από το πρωτότυπο στις 2021-08-28. https://web.archive.org/web/20210828052431/https://jpet.aspetjournals.org/content/174/2/206.long. Ανακτήθηκε στις 2020-11-02.

worldcat.org

La Mantia, L.; Milanese, C.; Mascoli, N.; D'Amico, R.; Weinstock-Guttman, B. (2007-01-24). «Cyclophosphamide for multiple sclerosis». Cochrane Database of Systematic Reviews (1): CD002819. doi:10.1002/14651858.CD002819.pub2. ISSN 1469-493X. PMID 17253481.
Singh, Jasvinder A.; Hossain, Alomgir; Kotb, Ahmed; Wells, George A. (2016). «Comparative effectiveness of immunosuppressive drugs and corticosteroids for lupus nephritis: a systematic review and network meta-analysis» (στα αγγλικά). Systematic Reviews 5 (1): 155. doi:10.1186/s13643-016-0328-z. ISSN 2046-4053. PMID 27619512. PMC 5020478. http://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-016-0328-z.

zenodo.org

«Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis». Lancet 340 (8822): 741–5. September 1992. doi:10.1016/0140-6736(92)92292-n. PMID 1356175. https://zenodo.org/record/1258313.